日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis.

β受体阻滞剂通过调节神经免疫肿瘤轴延长前列腺癌患者对雄激素剥夺疗法的反应时间

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-06644-7
Thulin Malin Hagberg, Ramberg Håkon, Nielsen Heidi Kristin, Grytli Helene Hartvedt, Sivanesan Shivanthe, Pandya Abhilash D, Seip Kotryna, Andressen Kjetil Wessel, Linder Anna, Øijordsbakken Miriam, Poutanen Matti, Katz Betina, Halvorsen Bente, Mælandsmo Gunhild Mari, Taskén Kristin Austlid
肿瘤
前列腺癌
发表日期：2025
文献求助 收藏

Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer.

化疗耐药肿瘤细胞分泌组增强了三阴性乳腺癌的免疫抑制作用

期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-025-02082-x
Skourti Eleni, Seip Kotryna, Mensali Nadia, Jabeen Shakila, Juell Siri, Øynebråten Inger, Pettersen Solveig, Engebraaten Olav, Corthay Alexandre, Inderberg Else Marit, Dolznig Helmut, Mælandsmo Gunhild Mari, Egeland Eivind Valen, Prasmickaite Lina
肿瘤
乳腺癌
发表日期：2025
文献求助 收藏

The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy

SRC家族是三阴性乳腺癌（对化疗产生耐药性）的治疗靶点。

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-024-02875-5
Egeland, Eivind Valen; Seip, Kotryna; Skourti, Eleni; Øy, Geir Frode; Pettersen, Solveig J; Pandya, Abhilash D; Dahle, Maria A; Haugen, Mads H; Kristian, Alexander; Nakken, Sigve; Engebraaten, Olav; Mælandsmo, Gunhild M; Prasmickaite, Lina
肿瘤
SRC
乳腺癌
肿瘤免疫
发表日期：2024
文献求助 收藏